BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38375477)

  • 1. Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study.
    Vogrig A; Tartaglia S; Dentoni M; Fabris M; Bax F; Belluzzo M; Verriello L; Bagatto D; Gastaldi M; Tocco P; Zoccarato M; Zuliani L; Pilotto A; Padovani A; Villagrán-García M; Davy V; Gigli GL; Honnorat J; Valente M
    Front Immunol; 2024; 15():1344184. PubMed ID: 38375477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination.
    Francis AG; Elhadd K; Camera V; Ferreira Dos Santos M; Rocchi C; Adib-Samii P; Athwal B; Attfield K; Barritt A; Craner M; Fisniku L; Iversen AKN; Leach O; Matthews L; Redmond I; O'Riordan J; Scalfari A; Tanasescu R; Wren D; Huda S; Leite MI; Fugger L; Palace J
    Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36411077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
    Jarius S; Bieber N; Haas J; Wildemann B
    J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system adverse events after ChAdOx1 vaccination.
    Maramattom BV; Lotlikar RS; Sukumaran S
    Neurol Sci; 2022 Jun; 43(6):3503-3507. PubMed ID: 35275317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review.
    Anamnart C; Tisavipat N; Owattanapanich W; Apiwattanakul M; Savangned P; Prayoonwiwat N; Siritho S; Rattanathamsakul N; Jitprapaikulsan J
    Mult Scler Relat Disord; 2022 Feb; 58():103414. PubMed ID: 35216789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic neuromyelitis after vaccination against SARS-CoV-2.
    Hernandez-Vega M; Orozco-Narvaez A; Reyes-Vaca JG; Rodriguez-Leyva I
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36574993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience.
    Monte G; Papetti L; Ferilli MAN; Ursitti F; Moavero R; Sforza G; Panella E; Tarantino S; Checchi MP; Vigevano F; Palma P; Valeriani M
    Front Immunol; 2023; 14():1106472. PubMed ID: 36761740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
    Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
    Front Immunol; 2021; 12():653786. PubMed ID: 33981305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Disseminated Encephalomyelitis and Acute Encephalitis Following Vaccination Against SARS-CoV-2: Two Case Reports and Review of Literature.
    Weidauer S; Zeitz A; Tafreshi M; Hattingen E; Arendt C
    Fortschr Neurol Psychiatr; 2023 Jul; 91(7-08):319-325. PubMed ID: 36931294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination - A self-controlled case series analysis.
    Morgan HJ; Clothier HJ; Sepulveda Kattan G; Boyd JH; Buttery JP
    Vaccine; 2024 Apr; 42(9):2212-2219. PubMed ID: 38350771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination.
    Vogrig A; Janes F; Gigli GL; Curcio F; Negro ID; D'Agostini S; Fabris M; Valente M
    Clin Neurol Neurosurg; 2021 Sep; 208():106839. PubMed ID: 34325334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
    Li X; Raventós B; Roel E; Pistillo A; Martinez-Hernandez E; Delmestri A; Reyes C; Strauss V; Prieto-Alhambra D; Burn E; Duarte-Salles T
    BMJ; 2022 Mar; 376():e068373. PubMed ID: 35296468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2.
    Sriwastava S; Tandon M; Podury S; Prasad A; Wen S; Guthrie G; Kakara M; Jaiswal S; Subedi R; Elkhooly M; Lisak RP
    J Neurol; 2021 Dec; 268(12):4448-4478. PubMed ID: 34009454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute central nervous system inflammation following COVID-19 vaccination: An observational cohort study.
    Lee S; Muccilli A; Schneider R; Selchen D; Krysko KM
    Mult Scler; 2023 Apr; 29(4-5):595-605. PubMed ID: 36840605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal cord involvement in COVID-19: A review.
    Garg RK; Paliwal VK; Gupta A
    J Spinal Cord Med; 2023 May; 46(3):390-404. PubMed ID: 33705268
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute Disseminated Encephalomyelitis After SARS-CoV-2 Vaccination.
    Ahmad HR; Timmermans VM; Dakakni T
    Am J Case Rep; 2022 Jun; 23():e936574. PubMed ID: 35717556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: A systematic review.
    Nabizadeh F; Noori M; Rahmani S; Hosseini H
    J Clin Neurosci; 2023 May; 111():57-70. PubMed ID: 36963124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kong L; Wang X; Chen H; Shi Z; Lang Y; Zhang Y; Zhou H
    Mult Scler Relat Disord; 2022 Dec; 68():104167. PubMed ID: 36170773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.